ACE2 Citations (3)

Originally described in: Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q, Hughes TA, Kelkar A, Yu X, Cheng K, Park S, Huang WC, Lovell JF, Neelamegham S Elife. 2020 Oct 26;9. pii: 61552. doi: 10.7554/eLife.61552. PubMed Journal

---

Articles Citing ACE2

Articles
Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity. Yang Q, Kelkar A, Sriram A, Hombu R, Hughes TA, Neelamegham S. Sci Adv. 2022 Sep 23;8(38):eabq8678. doi: 10.1126/sciadv.abq8678. Epub 2022 Sep 23. PubMed
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2. Maeda Y, Toyoda M, Kuwata T, Terasawa H, Tokugawa U, Monde K, Sawa T, Ueno T, Matsushita S. Int J Mol Sci. 2024 Jan 22;25(2):1353. doi: 10.3390/ijms25021353. PubMed
Structural basis for raccoon dog receptor recognition by SARS-CoV-2. Hsueh FC, Shi K, Mendoza A, Bu F, Zhang W, Aihara H, Li F. PLoS Pathog. 2024 May 6;20(5):e1012204. doi: 10.1371/journal.ppat.1012204. eCollection 2024 May. PubMed

If you have published an article using this material, please email us at to have your article added to this page.